Aortic Dissection Detection
AI-powered detection of aortic dissection in chest CT
Software · Cloud SaaSCompany source
Company profile
About AVICENNA.AI
Avicenna.AI is a medical imaging AI company leading the next generation of healthcare with a comprehensive suite of radiology solutions focused on emergency imaging and incidental findings. The company's AI-driven platform is designed around patient management with the goal of accelerating and improving therapeutic decision-making processes for better quality of care, improved patient outcomes, and cost reduction. The company's solutions span multiple clinical areas including neurovascular conditions (intracranial hemorrhage, large vessel occlusion, ASPECT score), spine injuries (cervical spine fracture, vertebral compression fracture), and chest emergencies (aortic dissection, pulmonary embolism, incidental pulmonary embolism). Their technology reduces interpretation time by delivering fast and reliable insights through advanced algorithms, enabling healthcare teams to recognize conditions early and make quicker decisions. Avicenna.AI's platform enhances radiology workflow by handling routine tasks, allowing radiologists to process larger volumes of cases in shorter timeframes. This increased productivity helps radiology departments manage growing workloads, reduce turnaround times, and enhance patient satisfaction through timely reports and interventions. The company serves hospitals, health systems, and teleradiology networks, with notable clients including Telediag (France's teleradiology leader), UC Irvine, and CHU Bordeaux. The company is committed to advancing healthcare through clinical publications covering validation studies and performance assessments that demonstrate the effectiveness of their AI solutions in improving diagnostic accuracy and workflow efficiency.
Company description AVICENNA.AI official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Work at AVICENNA.AI?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Aortic Dissection
- Cervical spine fracture
- Incidental Pulmonary embolism
- Intracranial Hemorrhage
- Large Vessel Occlusion
- Pulmonary embolism
- Stroke
- Vertebral compression fracture
Who it serves
- Health Systems
- Hospitals
- Radiology Departments
- Teleradiology Networks
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: PACS.
Geographic context
MarketsEurope · France · United States
Company sourceOfficial website
Company milestones
Platform expansion
40% increase in exam demand handled by clients using Avicenna.AI solutions (2021-2022 period mentioned by Telediag)
Partnerships
Recorded partners
- CHU Bordeaux
- Telediag
- UC Irvine
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
ASPECT Score
Automated ASPECT scoring for stroke assessment
Software · Cloud SaaSCompany source
AVI Platform
Comprehensive AI radiology platform for emergency imaging
Platform · Cloud SaaSCompany source
Cervical Spine Fracture Detection
AI detection of cervical spine fractures in trauma imaging
Software · Cloud SaaSCompany source
Incidental Pulmonary Embolism Detection
AI detection of incidental pulmonary embolism findings
Software · Cloud SaaSCompany source
Intracranial Hemorrhage Detection
AI-powered detection of intracranial hemorrhage in CT scans
Software · Cloud SaaSCompany source
Large Vessel Occlusion Detection
AI detection of large vessel occlusions in stroke imaging
Software · Cloud SaaSCompany source
Pulmonary Embolism Detection
AI detection of pulmonary embolism in chest CT
Software · Cloud SaaSCompany source
Vertebral Compression Fracture Detection
AI detection of vertebral compression fractures
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Multicenter, Multinational, and Multivendor Validation of an Artificial Intelligence Application for Acute Cervical Spine Fracture Detection on CT.Diagnostics (Basel, Switzerland) · Jan 7, 2026
Performance of an artificial intelligence tool for multi-step acute stroke imaging: A multicenter diagnostic study.European journal of radiology open · Dec 1, 2025
Deep learning-driven incidental detection of vertebral fractures in cancer patients: advancing diagnostic precision and clinical management.La Radiologia medica · Oct 1, 2025
Deep learning-based algorithm for automatic detection of incidental pulmonary embolism on contrast-enhanced CT: a multicenter multivendor study.Radiology advances · Jul 1, 2025
Automated vertebral compression fracture detection and quantification on opportunistic CT scans: a performance evaluation.Clinical radiology · Apr 1, 2025
Deep Learning-Based ASPECTS Algorithm Enhances Reader Performance and Reduces Interpretation Time.AJNR. American journal of neuroradiology · Mar 4, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
CINA-CSpineK240942 · 510k · Sep 12, 2024
CINA-VCFK240612 · 510k · May 31, 2024
CINA-ASPECTSK233342 · 510k · Mar 15, 2024
CINA-iPEK233968 · 510k · Mar 13, 2024
CINAK221716 · 510k · Nov 22, 2022
CINA CHESTK210237 · 510k · May 19, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Interpretation time reduction
Results available within 2-5 minutes, accelerating radiologist interpretation time
Workflow efficiency
Radiologists can process larger volume of cases within shorter timeframe
Turnaround time reduction
Reduced turnaround times for radiology departments
Patient satisfaction improvement
Enhanced through timely reports and interventions
Diagnostic confidence
AI provides extra 'set of eyes' improving overall confidence and efficiency
CHU Bordeaux
Automated one-click AI solution integrated with CT scan and PACS workflow for detecting findings without manual intervention
Fully automated workflow with images processed during CT scan and automatically sent to PACS with alerts for detected findings
Telediag
Teleradiology network using Stroke and Chest emergency AI tools to handle 40% increase in exam volume while maintaining 24/7 service quality
Results delivered within 2-5 minutes, enabling accelerated interpretation time and better patient outcomes despite 40% increase in demand
UC Irvine
Busy radiology practice using AI-assisted preliminary review to prioritize patients with positive findings and optimize clinical workflow
Improved confidence and efficiency through AI-provided 'extra set of eyes' for all exams
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Paul Cayot
Representative
Daniel Chow
Radiologist
Vincent Dousset
Representative
06 · Company updates
Updates from AVICENNA.AI
Recent articles published on AVICENNA.AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.